Clearance Summary
EFAI Chestsuite XR Malpositioned ETT Assessment System (ETT-XR-100) received FDA 510(k) clearance under submission number K242821, sponsored by Ever Fortune.Ai, Co., Ltd.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Radiology review panel. The statutory decision date of record is 2025-02-20.
- Submission: K242821
- Applicant / Sponsor: Ever Fortune.Ai, Co., Ltd.
- Clearance pathway: Traditional
- Review panel: Radiology
- Device class: Class II
- Regulation citation: 21 CFR 892.2080
- Decision date: 2025-02-20
Classification & Regulation
This clearance is catalogued under FDA product code QAS and 21 CFR 892.2080, within the Radiology review panel as a Class II device.